0001104659-23-073231.txt : 20230621
0001104659-23-073231.hdr.sgml : 20230621
20230621105848
ACCESSION NUMBER: 0001104659-23-073231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AUBERTON-HERVE ANDRE-JACQUES
CENTRAL INDEX KEY: 0001730329
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54717
FILM NUMBER: 231028349
MAIL ADDRESS:
STREET 1: 18 CHEMIN DE LA VIERGE NOIRE
CITY: LA TRONCHE
STATE: I0
ZIP: 38700
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bionik Laboratories Corp.
CENTRAL INDEX KEY: 0001508381
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 271340346
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 80 COOLIDGE HILL ROAD
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 1-617-926-4800
MAIL ADDRESS:
STREET 1: 80 COOLIDGE HILL ROAD
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Drywave Technologies, Inc.
DATE OF NAME CHANGE: 20130814
FORMER COMPANY:
FORMER CONFORMED NAME: Strategic Dental Management Corp.
DATE OF NAME CHANGE: 20101220
4
1
tm2319148-4_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-13
0
0001508381
Bionik Laboratories Corp.
BNKL
0001730329
AUBERTON-HERVE ANDRE-JACQUES
C/O BIONIK LABORATORIES CORP.
80 COOLIDGE HILL ROAD
WATERTOWN
MA
02472
1
0
0
0
0
Common Stock
2023-06-13
4
C
0
186111
0.60
A
1109271
I
Shares held through Star SCI
Common Stock
10693
I
Shares held through 4A Consulting and Engineering
Common Stock
95149
D
Convertible Promissory Note
0.60
2023-06-13
4
P
0
1
220000
A
2024-06-01
Common Stock, par value $0.001 per share
366667
1
I
Through Star SCI
Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock
The convertible promissory note (the "Note") will be convertible into common stock of the Issuer upon the following events on the following terms: (a) on June 1, 2024 without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to $0.60 per share; and (b) upon the consummation of the next equity or equity linked round of financing of the Issuer for cash proceeds (the "Qualified Financing"), without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to the lesser of (a) the issue price per share in the Qualified Financing and (b) $0.60 per share.
/s/ Andre-Jacques Auberton-Herve
2023-06-20